PHARMAZZ, INC.

Profile

Company Names

PHARMAZZ, INC.

Addresses

50 W 75TH ST, STE 105, WILLOWBROOK, IL 60527

50 W 75TH ST, STE 106, WILLOWBROOK, IL 60527

Phone Numbers

630-780-6087

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$31,707,603.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2025-05-27 
$10,037,500.00 
$25,037,500.00 
$15,000,000.00 
Equity 
8
2024-08-15 
$7,500,000.00 
$15,000,000.00 
$7,500,000.00 
 
7
2024-02-02 
$150,000.00 
$6,000,000.00 
$5,850,000.00 
 
6
2023-10-24 
$450,000.00 
$15,000,000.00 
$14,550,000.00 
 
5
2022-10-18 
$2,300,000.00 
$6,550,000.00 
$4,250,000.00 
Debt 
4
2021-04-12 
$5,450,000.00 
$5,450,000.00 
$0.00 
Debt 
3
2020-02-14 
$1,405,500.00 
$5,000,000.00 
$3,594,500.00 
Equity 
2
2018-07-31 
$3,691,000.00 
$3,691,000.00 
$0.00 
Equity 
1
2018-01-18 
$723,603.00 
$723,603.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
COSTELLO 
EXECUTIVE OFFICER
ANIL 
 
GULATI 
EXECUTIVE OFFICER, DIRECTOR
SUNIL 
 
GULATI 
EXECUTIVE OFFICER
JANE 
 
KIERNAN 
DIRECTOR
DHARMINDER 
 
MARWAH 
DIRECTOR, EXECUTIVE OFFICER
JAMES 
 
MCCONNELL 
DIRECTOR
JAMES 
 
MCDONNELL 
DIRECTOR
GURU 
 
REDDY 
EXECUTIVE OFFICER
AJIT 
 
SRIMAL 
DIRECTOR, EXECUTIVE OFFICER
DANIEL 
 
STAUDER 
EXECUTIVE OFFICER
DANIEL 
P. 
STAUDER 
EXECUTIVE OFFICER
GAYLORD 
 
TOFT 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-05-27 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2024-08-15 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2024-02-02 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2023-10-24 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2022-10-18 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2021-04-12 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2021-04-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-14 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-31 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#